182 related articles for article (PubMed ID: 1495937)
61. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study.
Tomoda H; Kakeji Y; Furusawa M
J Surg Oncol; 1993 Jul; 53(3):144-8. PubMed ID: 8331935
[TBL] [Abstract][Full Text] [Related]
63. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators.
Heimann TM; Oh SC; Martinelli G; Szporn A; Luppescu N; Lembo CA; Kurtz RJ; Fasy TM; Greenstein AJ
Am J Surg; 1992 Jul; 164(1):13-7. PubMed ID: 1626600
[TBL] [Abstract][Full Text] [Related]
64. [Clinicopathological studies of nuclear DNA distribution in colorectal cancer].
Kosaka T; Kamata T; Ishida T; Kato M; Yamaguchi A; Yonemura Y; Miyazaki I
Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1705-9. PubMed ID: 3447036
[TBL] [Abstract][Full Text] [Related]
65. Cytophotometric DNA-analysis of bone-tumors. A new method for preparing formalin-fixed tissue and the regarding of DNA-malignancy grade and its prognostic value.
Adler CP; Neuburger M; Herget GW; Klemm CE; Saur S
Pathol Res Pract; 1996 May; 192(5):437-45. PubMed ID: 8832748
[TBL] [Abstract][Full Text] [Related]
66. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
[TBL] [Abstract][Full Text] [Related]
67. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
Cibas ES; Melamed MR; Zaman MB; Kimmel M
Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
[TBL] [Abstract][Full Text] [Related]
68. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma.
Sun XF; Rütten S; Zhang H; Nordenskjöld B
J Clin Oncol; 1999 Jun; 17(6):1745-50. PubMed ID: 10561211
[TBL] [Abstract][Full Text] [Related]
69. c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
APMIS; 1995 Apr; 103(4):309-15. PubMed ID: 7612263
[TBL] [Abstract][Full Text] [Related]
70. DNA index as a significant predictor of recurrence in colorectal cancer.
Tomoda H; Baba H; Saito T; Wada S
Dis Colon Rectum; 1998 Mar; 41(3):286-90. PubMed ID: 9514422
[TBL] [Abstract][Full Text] [Related]
71. Flow cytometric DNA index in the prognosis of colorectal cancer.
Giaretti W; Danova M; Geido E; Mazzini G; Sciallero S; Aste H; Scivetti P; Riccardi A; Marsano B; Merlo F
Cancer; 1991 Apr; 67(7):1921-7. PubMed ID: 2004305
[TBL] [Abstract][Full Text] [Related]
72. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
Jones EC; McNeal J; Bruchovsky N; de Jong G
Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
[TBL] [Abstract][Full Text] [Related]
73. Patterns of DNA-ploidy in operable colorectal carcinoma: a prospective study of 100 cases.
Russo A; Bazan V; Plaja S; Leonardi P; Bazan P
J Surg Oncol; 1991 Sep; 48(1):4-10. PubMed ID: 1890838
[TBL] [Abstract][Full Text] [Related]
74. Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study?
Meling GI; Rognum TO; Clausen OP; Chen Y; Lunde OC; Schlichting E; Wiig JN; Hognestad J; Bakka A; Havig O
Cancer; 1991 Mar; 67(6):1642-9. PubMed ID: 2001553
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of DNA flow cytometry in sympathoadrenal paragangliomas.
García-Escudero A; de Miguel-Rodríguez M; Moreno-Fernández A; Navarro-Bustos G; Galera-Ruiz H; Galera-Davidson H
Anal Quant Cytol Histol; 2001 Jun; 23(3):238-44. PubMed ID: 11444194
[TBL] [Abstract][Full Text] [Related]
76. A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer.
Armitage NC; Ballantyne KC; Sheffield JP; Clarke P; Evans DF; Hardcastle JD
Cancer; 1991 May; 67(10):2599-604. PubMed ID: 2015560
[TBL] [Abstract][Full Text] [Related]
77. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer.
Geido E; Sciutto A; Rubagotti A; Oliani C; Monaco R; Risio M; Giaretti W
Cytometry; 2002 Aug; 50(4):216-24. PubMed ID: 12210601
[TBL] [Abstract][Full Text] [Related]
78. DNA analysis in hepatoblastoma by flow and image cytometry.
Schmidt D; Wischmeyer P; Leuschner I; Sprenger E; Langenau E; von Schweinitz D; Harms D
Cancer; 1993 Nov; 72(10):2914-9. PubMed ID: 8221557
[TBL] [Abstract][Full Text] [Related]
79. DNA quantification as a prognostic factor in colorectal adenocarcinoma.
Azúa J; Romeo P; Morales M; Castiella T; Azúa J
Anal Quant Cytol Histol; 1999 Dec; 21(6):468-72. PubMed ID: 10626014
[TBL] [Abstract][Full Text] [Related]
80. Analysis of subclonal expansion of colorectal carcinomas by flow cytometry.
Sugai T; Nakamura S; Habano W; Uesugi N; Sato H; Funato O; Sasou S; Orii S; Itoh C
Virchows Arch; 1999 May; 434(5):437-41. PubMed ID: 10389627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
